| Rus | Eng |
On May 14, 2018 at the meeting of the Academic Council was held a aceremony for awarding Doctor of Engineering Sciences, Professor of Materials Science, Yury Gogotsi, founder and director of Drexel Nanomaterials Institute, Drexel University (USA), with the title of Honored Doctor of the National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute".
The ceremony was opened by the rector of the KPI named after Igor Sikorsky, Academician of the National Academy of Sciences of Ukraine, Mikhail Zgurovsky. He spoke about the life path, outstanding scientific achievements and the weighty personal contribution of Yuri Gogotsi to the development of scientific and educational cooperation of the KPI named after Igor Sikorsky with the Drexel Nanomaterials Institute, Drexel University (USA).
Yury Georgievich Gogotsi was born in 1961 in the Kyiv family of the famous Ukrainian scientist Professor George Gogotsi. He is related with the National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute" not only as a scientist, but also as its graduate - in 1984 Yury Gogotsi graduated from the Faculty of Engineering and Physics of the KPI, the Department of High-Temperature Materials and Powder Metallurgy, and two years later here he became a Ph.D. Candidate of Science in Physical Chemistry (he worked at the Department of Physical Chemistry of the Chemical and Technological Faculty under the supervision of Professor Vladimir Lavrenko). By the way, members of the family of Yuri Gogotsi - his father and brother, who attended the ceremony, also at various times graduated from the KPI.
However, Yuri Gogotsi worked and studied not only in the KPI. In his scientific biography there are also pages related to Frantsevich Institute of Problems of Materials Science NAS of Ukraine, where in 1995 he received a Doctor of Science (D.Sc.) degree in Materials Engineering from the National Academy of Sciences in Ukraine. Notable landmarks on his research path were also internships and work at the University of Karlsruhe (Germany), the Tokyo Technical University (Japan), the University of Oslo (Norway), the University of Tubingen (Germany) and the Illinois University in Chicago (USA). Since 2003 he is Professor of Materials Science, Honored Professor of Drexel University in Philadelphia (USA), in which he founded Nanomaterials Institute.
Professor Gogotsi and his colleagues synthesized and studied a large family of fundamentally new two-dimensional nanomaterials - MXenes (MXenes - two-dimensional carbides and nitrides of transition metals - new materials with new properties that were not known before and which can become the basis for storing electrical energy and making new electronic devices). He developed a general approach to the synthesis of porous and low-dimensional materials using selective extraction of elements / components that can be used to create nanoporous carbon, carbon nanotubes, graphene, 2D carbides, etc. In addition, Professor Gogotsi discovered and described new forms of carbon - conical and polygon crystals. Yury Gogotsi also discovered a new metastable phase of silicon. For the first time, the presence and anomalously slow progress of water in carbon nanotubes was demonstrated by electron microscopy and others.
After the Honorary Doctorate award, Professor Gogotsi addressed the audience with a short nomination lecture on the past and prospects for the development of the KPI named after Igor Sikorsky as the leading institution of higher technical education in Ukraine.
Source http://kpi.ua/2018-05-14


MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Our team was very delighted to take part in International Symposium "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene event in Europe this year!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.